Literature DB >> 19900952

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

M Sundqvist1, P Geli, D I Andersson, M Sjölund-Karlsson, A Runehagen, H Cars, K Abelson-Storby, O Cars, G Kahlmeter.   

Abstract

OBJECTIVES: The worldwide rapid increase in antibiotic-resistant bacteria has made efforts to prolong the lifespan of existing antibiotics very important. Antibiotic resistance often confers a fitness cost in the bacterium. Resistance may thus be reversible if antibiotic use is discontinued or reduced. To examine this concept, we performed a 24 month voluntary restriction on the use of trimethoprim-containing drugs in Kronoberg County, Sweden.
METHODS: The intervention was performed on a 14 year baseline of monthly data on trimethoprim resistance and consumption. A three-parameter mathematical model was used to analyse the intervention effect. The prerequisites for reversion of resistance (i.e. fitness cost, associated resistance and clonal composition) were studied on subsets of consecutively collected Escherichia coli from urinary tract infections.
RESULTS: The use of trimethoprim-containing drugs decreased by 85% during the intervention. A marginal but statistically significant effect on the increase in trimethoprim resistance was registered. There was no change in the clonal composition of E. coli and there was no measurable fitness cost associated with trimethoprim resistance in clinical isolates. The frequency of associated antibiotic resistances in trimethoprim-resistant isolates was high.
CONCLUSIONS: A lack of detectable fitness cost of trimethoprim resistance in vitro together with a strong co-selection of other antibiotics could explain the rather disappointing effect of the intervention. The result emphasizes the low possibility of reverting antibiotic resistance once established and the urgent need for the development of new antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900952     DOI: 10.1093/jac/dkp387

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  58 in total

1.  Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints.

Authors:  Göran Kronvall
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

2.  Association of composite IS26-sul3 elements with highly transmissible IncI1 plasmids in extended-spectrum-beta-lactamase-producing Escherichia coli clones from humans.

Authors:  Tânia Curiao; Rafael Cantón; M Pilar Garcillán-Barcia; Fernando de la Cruz; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

Review 3.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

Review 4.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

Review 5.  Prediction of antibiotic resistance: time for a new preclinical paradigm?

Authors:  Morten O A Sommer; Christian Munck; Rasmus Vendler Toft-Kehler; Dan I Andersson
Journal:  Nat Rev Microbiol       Date:  2017-07-31       Impact factor: 60.633

Review 6.  Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.

Authors:  Fernando Baquero; Teresa M Coque; Fernando de la Cruz
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

7.  Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department.

Authors:  Florian Hitzenbichler; Michaela Simon; Thomas Holzmann; Michael Iberer; Markus Zimmermann; Bernd Salzberger; Frank Hanses
Journal:  Infection       Date:  2018-01-24       Impact factor: 3.553

Review 8.  Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence.

Authors:  Eirini Christaki; Markella Marcou; Andreas Tofarides
Journal:  J Mol Evol       Date:  2019-10-28       Impact factor: 2.395

9.  Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England.

Authors:  Mohamed O Ahmed; Peter D Clegg; Nicola J Williams; Keith E Baptiste; Malcolm Bennett
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-04-07       Impact factor: 3.944

10.  Molecular characterisation of trimethoprim resistance in Escherichia coli and Klebsiella pneumoniae during a two year intervention on trimethoprim use.

Authors:  Alma Brolund; Martin Sundqvist; Gunnar Kahlmeter; Malin Grape
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.